Hyperhidrosis palmaris (HP) is a rather common disease in Taiwan. Taiwan is a leading nation in terms of the surgical treatment of this disease using thoracic endoscopic sympathectomy. However, the currently available epidemiological information regarding HP is insufficient. To date, the incidence of HP and the percentage of patients treated surgically have not been reported. We investigated the incidence of Patients who underwent surgery were identified by the treatment codes 83026C (dorsal sympathectomy) and 83085B (transendoscopic dorsal sympathectomy, TES). Factors included in the analysis included age, sex, time of operation and hospitalization for surgery. In total, 15,839 patients with HP were identified. The incidence was 7.2 per 10,000 beneficiaries. The study sample included 7,603 males with an incidence of 6.9 per 10,000 beneficiaries, and 8,236 females with an incidence of 7.4 per 10,000 beneficiaries. The incidence was highest among patients aged 20-29 years old. The incidence decreased with increasing age (MantelHaenszel χ 2 test for trend, p < 0.001), and 3,755 cases (23.7%) received an operation, of which 1,733 were male (22.8% of all male patients) and 2,022 were female (24.6% of all female patients) (p = 0.009). Of these, 99.3% underwent transendoscopic dorsal sympathectomy, and 94.7% underwent surgery within 1 month of the initial diagnosis. Males underwent surgery sooner than females (p = 0.004). Adjusted multivariate logistic regression analysis showed that patients aged 20-29 were more likely to undergo surgery than the other age groups (odds ratio: 2.28; 95% confidence interval: 2.07-2.52). Regional hospitals had the highest chance to perform the operation (odds ratio: 4.87; 95% confidence interval: 4.41-5.37). Here, we have reported the incidence of HP in Taiwan in 2004 and concluded that the incidence was higher in females than in males. About onequarter of patients underwent surgery, mostly within 1 month after attending an outpatient
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Hyperhidrosis is mainly found at the palms, soles, and axillae [1, 4, [6] [7] [8] [9] . Palmar hyperhidrosis is the most frequent presentation type of this sudomotor regulation disorder [9] . However, the prevalence seems to be higher in Western countries (up to 51%) and people show greater concern about axillary hyperhidrosis than Asian people [8, 10] . Hyperhidrosis has an ethnic preponderance [11, 12] and frequently shows a familial predisposition [1, 2, 8, 9, 13] . There is some evidence of vertical transmission [2] , but there is still no evidence for an association with genetic polymorphisms [14] .
Diagnosis of this disorder is mainly based on the patient's subjective complaints. Minor's iodine-starch test [4] , gravimetric quantification, power spectrum analysis of heart rate variability [5] , and skin responses [15] add little to the diagnosis of hyperhidrosis [10] or surveying its incidence in the general population. The treatment options for hyperhidrosis include antiperspirants, anticholinergic drugs, iontophoresis, surgery, and botulinum toxin injection [16] . Surgical treatment by thoracic endoscopic sympathectomy (TES) is reported to be more effective than and superior to medication [1, 6, 17, 18] . Taiwan is a leading nation in terms of using this surgical technique [1, 6, [19] [20] [21] .
To our knowledge, there are only three epidemiological studies of hyperhidrosis [2, 3, 10, 13] , and all report prevalence instead of incidence. A pilot study reported a prevalence of 0.6-1.0% among young Israelis [12] . A survey among adolescent Chinese reported a prevalence of 4.36% [9, 13] . Strutton et al reported that 2.8% of the general population in the United States had hyperhidrosis across all ages, locations, and severities [10] . However, none of the above studies measured the actual incidence of treated hyperhidrosis and the frequency of patients who underwent surgical treatment.
Taiwan's National Health Insurance (NHI) is a universal health insurance program that covers more than 98% of the total population in Taiwan [22] . We investigated the age-and sex-specific incidence of the disease, and the frequency of surgical treatment in 2004, by sampling Taiwan's NHI database.
METHODS
Data were retrieved from Taiwan's NHI database [22] . Briefly, the NHI plan was implemented in 1995 and has since accumulated 22.28 million administrative and claims records, and covers approximately 98% of the total population of Taiwan [23] . These database form the largest such collection in the world. The NHI Bureau (NHIB) has established a uniform system to control the quality of medical services. Patient treatment is controlled by a Professional Peer Review Committee and a Disputes Settlement Board to ensure a high standard of treatment by the contracted hospitals, doctors, and other relevant medical care institutions. The National Health Research Institute (NHRI) cooperated with the NHIB to establish a NHI research database. The NHRI safeguards the privacy and confidentiality of the subjects, and routinely transfers the health insurance data from the NHIB to their own database to enable health researchers to analyze and improve the health of citizens in Taiwan. This system provides a highly reliable database containing patient treatment statistics to researchers. 
Statistical analysis
The data was expressed as the number of cases and as percentages. Pearson's χ 2 test was used to evaluate the significance of differences between groups. The Mantel-Haenszel χ 2 test was used to examine trends.
Logistic regression was used for multivariate analyses. A p value of less than 0.05 was regarded as significant. All analyses were performed using SPSS version 13.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
A total of 15,839 patients were newly diagnosed with HP in 2004. The treated incidence was 7.2 per 10,000 beneficiaries. These included 7,603 males, with an incidence of 6.9 per 10,000 male beneficiaries, and 8,236 females, with an incidence of 7.4 per 10,000 female beneficiaries. The incidence was significantly higher in females than in males for all age groups, except those aged < 20 years old. The incidence was highest in those aged 20-29 years old. The incidence of HP decreased with increasing age (p < 0.001) within the total population, and among males and females (Table 1) . Of the diagnosed patients, 3,755 (23.7%) underwent surgery in 2004 (Table 2) , including 1,733 males (22.8% of all male patients) and 2,022 females (24.6% of all female patients); thus, females had a significant higher rate of undergoing surgery than males (p = 0.009). Overall, 3,728 cases (99.3%) underwent TES and 27 cases (0.7%) underwent DS; there was no significant sex difference between the methods used for the operation. Most of the patients (94.7%) underwent surgery within 1 month of the initial diagnosis; however, more males underwent surgery within 1 month of the initial diagnosis than females (p = 0.004). 
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Univariate logistic regression analysis (Table 3) showed that females were more likely to undergo surgery than males [odds ratio (OR): 1.10; 95% confidence interval (CI): 1.02-1.19]; however, after adjustment for other factors, this association was lost. Patients aged 20-29 years were most likely to undergo surgery compared with the other age groups (OR: 2.87; 95% CI: 2.62-3.15). The surgery was more commonly performed at regional hospitals than at local community hospitals or academic medical centers (OR: 6.31; 95% CI: 5.76-6.91).
DISCUSSION
To date, no population-based studies have reported the incidence of treatment for hyperhidrosis. A study of a young Israeli population reported a rate of 0.6-1.0% for hyperhidrosis of all severities and locations and it was estimated that 25.0% of these individuals had severe hyperhidrosis [12] . However, this was a pilot study and the methodology was not fully described. Two recent studies have reported the prevalence of hyperhidrosis to be 2.8% within the general population of the United States, with an average age of 40 years [10] , and 4.59% in Chinese adolescents aged 15-22 years [9] . However, not all patients who suffer from hyperhidrosis are willing to visit a doctor or undergo surgery. It has been described that only 38% of subjects with reported hyperhidrosis have discussed their sweating with a health care professional [10] , and only 0.27% of patients resort to treatment at a clinic [9] . Here, we report incidence of treatment for HP of only 0.072% in 2004 (7.2 patients per 10,000 beneficiaries). Our data include patients presenting for treatment and those who actually need medical services. The need for treatment is a result of the interaction between the severity of the hyperhidrosis and the tolerance of the patient to hyperhidrosis. Compared with subjects with hyperhidrosis identified by a general survey, patients who received treatment had more severe hyperhidrosis. In a general survey, 93.87% of subjects were found to have lowgrade severity and only 6.12% of subjects had highgrade severity [9] . Conversely, in a study of 508 patients who were referred for botulinum toxin therapy, 90.2% of the patients had a higher grade of severity [8] .
The age of onset of primary hyperhidrosis was found to be 73% during childhood, 22% during adolescence and 5% during adulthood [1, 6] . However, people may not seek medical help until early adulthood [7] . The mean age of onset (14.05 years old) and the mean age at consultation (28.11 years old) [8] differ by about 14 years. The severity and frequency of sweating seems to decrease in older patients, such as those older than 50 years of age [7, 9] . Therefore, the reported prevalence among adolescents (4.59%) [9] may be higher than that of adults (2.8%) [10] . The delay in seeking medical service and the decreasing severity with aging explain the peak in incidence of treated HP at 20-29 years old in our series.
Previous studies have suggested that both sexes are affected equally [9, 10, 13] and there is currently no evidence of sex-linked genetic transmission [2] . However, females are more likely than males to discuss sweating with a health care professional [8, 10] . The higher incidence of treated HP among females in our series indicates greater willingness of females to attend a physician. Although the univariate analysis revealed females were more likely to undergo surgery than males, this association was lost after adjusting for age. Interestingly, not withstanding this significant sex difference, males underwent surgery sooner after attending the outpatient clinic than females did.
In this study, 23.7% of patients underwent surgery and 99.3% of these underwent TES. About 94.7% patients underwent surgery within 1 month after they first attended a clinic. TES has been used for cases of HP since around 1989 in Taiwan [1, 6, [19] [20] [21] and has become the standard procedure and treatment of choice for hyperhidrosis by neurosurgeons and thoracic surgeons worldwide [12, 17, 18, [24] [25] [26] . The quality of life of the patient is generally improved after surgery and the overall patient satisfaction rate was reported to be 78-86% [1, 6, 19, 20] . The long-term outcomes of TES still need to be fully evaluated. In this context, regional hospitals showed the highest utilization of this procedure, which may be due to better accessibility of the regional hospitals.
The most important and interesting epidemiological finding for HP is the proportion of patients who seek medical care and, of these, the number that receive an operation; this information is much more useful than the prevalence of the disease in the general population. Thus, we have reported important information on the incidence of treatment for HP. We conclude that the incidence of HP is highest in females and the peak incidence of treated HP is at 20-29 years old. About one-quarter of patients undergo surgery to treat this disease. In Taiwan, surgery was mostly performed within 1 month of the patient first attending an outpatient clinic and almost all cases were treated using TES.
